In the First Quarter of 2024, Telefield Medical Imaging Limited closed the transaction. The company amended the terms of the transaction. The company has received HKD 19,571,525 ($2.5 million) in its second and final tranche, led by new investor AEF Greater Bay Area Venture Fund, a fund managed by Gobi Partners, closing and received a total of HKD 59,571,525 ($60 million).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.15 CNY | -2.12% |
|
-1.56% | -11.51% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.51% | 7.57B | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Telefield Medical Imaging Limited announced that it has received HKD 59.571525 million in funding Gobi Partners